CXCL10 and neoplasm: As a possible approach is to use viral vectors such as lentiviruses or adenoviruses, as well as non-viral carriers such as nanoparticles and liposomes, may be employed to deliver the CXCL10 gene directly into tumor or immune cells to enhance local expression and boost the anti-tumor immune response.